Atlas Trials

An Efficacy and Safety Study of XP19986 in Subjects With Symptomatic GERD

Clinical trial NCT00557401 · COMPLETED

Trial details

NCT number
NCT00557401
Sponsor
XenoPort, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Gastroesophageal Reflux
Start date
2007-11-01
Primary completion
2008-09-01
Enrollment
156

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.